-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE 2-Elevar-Hengrui hit with third FDA rejection for liver cancer therapy over manufacturing concerns

Reuters·07/10/2026 17:06:48

Please log in to view news